Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan.

Hishinuma T, Tada T, Uchida H, Shimojima M, Kirikae T.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00124-19. doi: 10.1128/AAC.00124-19. Print 2019 Jun.

PMID:
30962328
2.

Molecular Characterization of Multidrug-Resistant Pseudomonas aeruginosa Isolates in Hospitals in Myanmar.

Tada T, Hishinuma T, Watanabe S, Uchida H, Tohya M, Kuwahara-Arai K, Mya S, Zan KN, Kirikae T, Tin HH.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02397-18. doi: 10.1128/AAC.02397-18. Print 2019 May.

PMID:
30803967
3.

Genetic and Transcriptomic Analyses of Ciprofloxacin-Tolerant Staphylococcus aureus Isolated by the Replica Plating Tolerance Isolation System (REPTIS).

Matsuo M, Hiramatsu M, Singh M, Sasaki T, Hishinuma T, Yamamoto N, Morimoto Y, Kirikae T, Hiramatsu K.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e02019-18. doi: 10.1128/AAC.02019-18. Print 2019 Feb.

PMID:
30509938
4.

Identification of a Novel Gene Associated with High-Level β-Lactam Resistance in Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strain Mu3 and Methicillin-Resistant S. aureus Strain N315.

Matsuo M, Yamamoto N, Hishinuma T, Hiramatsu K.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e00712-18. doi: 10.1128/AAC.00712-18. Print 2019 Feb.

PMID:
30455230
5.

Spread of GES-5 carbapenemase-producing Pseudomonas aeruginosa clinical isolates in Japan due to clonal expansion of ST235.

Hishinuma T, Tada T, Kuwahara-Arai K, Yamamoto N, Shimojima M, Kirikae T.

PLoS One. 2018 Nov 19;13(11):e0207134. doi: 10.1371/journal.pone.0207134. eCollection 2018.

6.

A carbapenem-resistant clinical isolate of Aeromonas hydrophila in Japan harbouring an acquired gene encoding GES-24 β-lactamase.

Uechi K, Tada T, Sawachi Y, Hishinuma T, Takaesu R, Nakama M, Nakasone I, Kirikae T, Fujita J.

J Med Microbiol. 2018 Nov;67(11):1535-1537. doi: 10.1099/jmm.0.000842. Epub 2018 Oct 5.

PMID:
30289383
7.

In Vitro Tolerance of Drug-Naive Staphylococcus aureus Strain FDA209P to Vancomycin.

Singh M, Matsuo M, Sasaki T, Morimoto Y, Hishinuma T, Hiramatsu K.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01154-16. doi: 10.1128/AAC.01154-16. Print 2017 Feb.

8.

Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.

Katayama Y, Sekine M, Hishinuma T, Aiba Y, Hiramatsu K.

Antimicrob Agents Chemother. 2016 May 23;60(6):3730-42. doi: 10.1128/AAC.00420-16. Print 2016 Jun.

9.

Complete Genome Sequence of Vancomycin-Intermediate Staphylococcus aureus Strain MI (HIP5827).

Hishinuma T, Katayama Y, Matsuo M, Sasaki T, Hiramatsu K.

Genome Announc. 2016 Mar 17;4(2). pii: e00123-16. doi: 10.1128/genomeA.00123-16.

10.

A mutation of RNA polymerase β' subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into "slow VISA".

Matsuo M, Hishinuma T, Katayama Y, Hiramatsu K.

Antimicrob Agents Chemother. 2015 Jul;59(7):4215-25. doi: 10.1128/AAC.00135-15. Epub 2015 May 4.

11.

Vancomycin-intermediate resistance in Staphylococcus aureus.

Hiramatsu K, Kayayama Y, Matsuo M, Aiba Y, Saito M, Hishinuma T, Iwamoto A.

J Glob Antimicrob Resist. 2014 Dec;2(4):213-224. doi: 10.1016/j.jgar.2014.04.006. Epub 2014 Jun 7. Review.

12.

"Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.

Saito M, Katayama Y, Hishinuma T, Iwamoto A, Aiba Y, Kuwahara-Arai K, Cui L, Matsuo M, Aritaka N, Hiramatsu K.

Antimicrob Agents Chemother. 2014 Sep;58(9):5024-35. doi: 10.1128/AAC.02470-13. Epub 2014 May 19.

13.

Acceleration of reinforcement learning by policy evaluation using nonstationary iterative method.

Senda K, Hattori S, Hishinuma T, Kohda T.

IEEE Trans Cybern. 2014 Dec;44(12):2696-705. doi: 10.1109/TCYB.2014.2313655. Epub 2014 Apr 10.

PMID:
24733037
14.

Genomic Basis for Methicillin Resistance in Staphylococcus aureus.

Hiramatsu K, Ito T, Tsubakishita S, Sasaki T, Takeuchi F, Morimoto Y, Katayama Y, Matsuo M, Kuwahara-Arai K, Hishinuma T, Baba T.

Infect Chemother. 2013 Jun;45(2):117-36. doi: 10.3947/ic.2013.45.2.117. Epub 2013 Jun 26. Review.

15.

Mutation of RNA polymerase β-subunit gene promotes heterogeneous-to-homogeneous conversion of β-lactam resistance in methicillin-resistant Staphylococcus aureus.

Aiba Y, Katayama Y, Hishinuma T, Murakami-Kuroda H, Cui L, Hiramatsu K.

Antimicrob Agents Chemother. 2013 Oct;57(10):4861-71. doi: 10.1128/AAC.00720-13. Epub 2013 Jul 22.

16.

SLC10A4 is a protease-activated transporter that transports bile acids.

Abe T, Kanemitu Y, Nakasone M, Kawahata I, Yamakuni T, Nakajima A, Suzuki N, Nishikawa M, Hishinuma T, Tomioka Y.

J Biochem. 2013 Jul;154(1):93-101. doi: 10.1093/jb/mvt031. Epub 2013 Apr 14.

PMID:
23589386
17.

Repeated treatment with nicotine induces phosphorylation of NMDA receptor NR2B subunit in the brain regions involved in behavioral sensitization.

Nakajima A, Kinugasa Y, Torii J, Hishinuma T, Tomioka Y, Yamada K, Yamakuni T.

Neurosci Lett. 2012 Aug 30;524(2):133-8. doi: 10.1016/j.neulet.2012.07.022. Epub 2012 Jul 20.

PMID:
22819974
18.

Simultaneous quantitation of sphingoid bases and their phosphates in biological samples by liquid chromatography/electrospray ionization tandem mass spectrometry.

Saigusa D, Shiba K, Inoue A, Hama K, Okutani M, Iida N, Saito M, Suzuki K, Kaneko T, Suzuki N, Yamaguchi H, Mano N, Goto J, Hishinuma T, Aoki J, Tomioka Y.

Anal Bioanal Chem. 2012 Jun;403(7):1897-905. doi: 10.1007/s00216-012-6004-9. Epub 2012 Apr 27.

PMID:
22538778
19.

Preparation of poly(3-hexylthiophene)/[6,6]-phenyl-C61-butyric acid methyl ester Langmuir-Blodgett bulk hetero junctions on indium tin oxide.

Kusano H, Ishikawa T, Satoh A, Sanda A, Hishinuma T, Kitagawa M.

J Nanosci Nanotechnol. 2012 Jan;12(1):719-24.

PMID:
22524046
20.

Effect of liquid whey feeding on fecal microbiota of mature and growing pigs.

Kobayashi Y, Itoh A, Miyawaki K, Koike S, Iwabuchi O, Iimura Y, Kobashi Y, Kawashima T, Wakamatsu J, Hattori A, Murakami H, Morimatsu F, Nakaebisu T, Hishinuma T.

Anim Sci J. 2011 Aug;82(4):607-15. doi: 10.1111/j.1740-0929.2011.00876.x. Epub 2011 Apr 20.

21.

Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3.

Matsuo M, Hishinuma T, Katayama Y, Cui L, Kapi M, Hiramatsu K.

Antimicrob Agents Chemother. 2011 Sep;55(9):4188-95. doi: 10.1128/AAC.00398-11. Epub 2011 Jul 11.

22.

walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.

Shoji M, Cui L, Iizuka R, Komoto A, Neoh HM, Watanabe Y, Hishinuma T, Hiramatsu K.

Antimicrob Agents Chemother. 2011 Aug;55(8):3870-81. doi: 10.1128/AAC.01563-10. Epub 2011 May 31.

23.

Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes.

Yamaguchi H, Takeuchi T, Okada M, Kobayashi M, Unno M, Abe T, Goto J, Hishinuma T, Shimada M, Mano N.

Biol Pharm Bull. 2011;34(3):389-95.

24.

Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulence.

Kaito C, Saito Y, Nagano G, Ikuo M, Omae Y, Hanada Y, Han X, Kuwahara-Arai K, Hishinuma T, Baba T, Ito T, Hiramatsu K, Sekimizu K.

PLoS Pathog. 2011 Feb 3;7(2):e1001267. doi: 10.1371/journal.ppat.1001267.

25.

Epidermal FABP (FABP5) regulates keratinocyte differentiation by 13(S)-HODE-mediated activation of the NF-κB signaling pathway.

Ogawa E, Owada Y, Ikawa S, Adachi Y, Egawa T, Nemoto K, Suzuki K, Hishinuma T, Kawashima H, Kondo H, Muto M, Aiba S, Okuyama R.

J Invest Dermatol. 2011 Mar;131(3):604-12. doi: 10.1038/jid.2010.342. Epub 2010 Nov 11.

26.

An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.

Cui L, Isii T, Fukuda M, Ochiai T, Neoh HM, Camargo IL, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K.

Antimicrob Agents Chemother. 2010 Dec;54(12):5222-33. doi: 10.1128/AAC.00437-10. Epub 2010 Sep 13.

27.

Simultaneous determination of guanidinosuccinic acid and guanidinoacetic acid in urine using high performance liquid chromatography/tandem mass spectrometry.

Saigusa D, Suzuki N, Takahashi M, Shiba K, Tanaka S, Abe T, Hishinuma T, Tomioka Y.

Anal Chim Acta. 2010 Sep 16;677(2):169-75. doi: 10.1016/j.aca.2010.08.005. Epub 2010 Aug 13.

PMID:
20837184
28.

Life cycle assessment of integrated municipal solid waste management systems, taking account of climate change and landfill shortage trade-off problems.

Tabata T, Hishinuma T, Ihara T, Genchi Y.

Waste Manag Res. 2011 Apr;29(4):423-32. doi: 10.1177/0734242X10379493. Epub 2010 Aug 10.

PMID:
20699290
29.

Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1.

Yamaguchi H, Sugie M, Okada M, Mikkaichi T, Toyohara T, Abe T, Goto J, Hishinuma T, Shimada M, Mano N.

Drug Metab Pharmacokinet. 2010;25(3):314-7.

30.

[Introducing hazard prediction training 'KYT' to undergraduate pharmacy education on patient safety].

Murai Y, Sato M, Yamaguchi H, Shimada M, Mano N, Goto J, Hishinuma T.

Yakugaku Zasshi. 2009 Nov;129(11):1367-73. Japanese.

31.

SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.

Toyohara T, Suzuki T, Morimoto R, Akiyama Y, Souma T, Shiwaku HO, Takeuchi Y, Mishima E, Abe M, Tanemoto M, Masuda S, Kawano H, Maemura K, Nakayama M, Sato H, Mikkaichi T, Yamaguchi H, Fukui S, Fukumoto Y, Shimokawa H, Inui K, Terasaki T, Goto J, Ito S, Hishinuma T, Rubera I, Tauc M, Fujii-Kuriyama Y, Yabuuchi H, Moriyama Y, Soga T, Abe T.

J Am Soc Nephrol. 2009 Dec;20(12):2546-55. doi: 10.1681/ASN.2009070696. Epub 2009 Oct 29.

32.

Neurobehavioral effects of tetrabromobisphenol A, a brominated flame retardant, in mice.

Nakajima A, Saigusa D, Tetsu N, Yamakuni T, Tomioka Y, Hishinuma T.

Toxicol Lett. 2009 Aug 25;189(1):78-83. doi: 10.1016/j.toxlet.2009.05.003. Epub 2009 May 20.

PMID:
19463927
33.

Cysteinyl leukotrienes enhance the degranulation of bone marrow-derived mast cells through the autocrine mechanism.

Kaneko I, Suzuki K, Matsuo K, Kumagai H, Owada Y, Noguchi N, Hishinuma T, Ono M.

Tohoku J Exp Med. 2009 Mar;217(3):185-91.

34.

The nutrient formula containing eicosapentaenoic acid and docosahexaenoic acid benefits the fatty acid status of patients receiving long-term enteral nutrition.

Munakata M, Nishikawa M, Togashi N, Nio E, Kobayashi Y, Omura K, Haginoya K, Tanaka S, Abe T, Hishinuma T, Chida N, Tsuchiya S, Onuma A.

Tohoku J Exp Med. 2009 Jan;217(1):23-8.

35.

Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry.

Hishinuma T, Suzuki K, Yamaguchi H, Yamagishi H, Koike T, Ohara S, Shimosegawa T, Mano N, Goto J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jul 1;870(1):38-45. doi: 10.1016/j.jchromb.2008.05.034. Epub 2008 Jun 12.

PMID:
18555753
36.

Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.

Yamagishi H, Koike T, Ohara S, Horii T, Kikuchi R, Kobayashi S, Abe Y, Iijima K, Imatani A, Suzuki K, Hishinuma T, Goto J, Shimosegawa T.

World J Gastroenterol. 2008 Apr 21;14(15):2406-10.

37.

Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers.

Yamagishi H, Koike T, Ohara S, Horii T, Kikuchi R, Kobayashi S, Abe Y, Iijima K, Imatani A, Suzuki K, Hishinuma T, Goto J, Shimosegawa T.

World J Gastroenterol. 2008 Apr 7;14(13):2049-54.

38.

Prostaglandin F(2alpha) regulates cytokine responses of mast cells through the receptors for prostaglandin E.

Kaneko I, Hishinuma T, Suzuki K, Owada Y, Kitanaka N, Kondo H, Goto J, Furukawa H, Ono M.

Biochem Biophys Res Commun. 2008 Mar 14;367(3):590-6. doi: 10.1016/j.bbrc.2008.01.002. Epub 2008 Jan 9.

PMID:
18190789
39.

Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes.

Yamaguchi H, Kobayashi M, Okada M, Takeuchi T, Unno M, Abe T, Goto J, Hishinuma T, Mano N.

Cancer Lett. 2008 Feb 18;260(1-2):163-9. Epub 2007 Dec 20.

PMID:
18082941
40.

Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt/forkhead box class O1-dependent pathway in hepatocytes.

Kitazawa M, Ohizumi Y, Oike Y, Hishinuma T, Hashimoto S.

J Pharmacol Exp Ther. 2007 Dec;323(3):787-93. Epub 2007 Sep 5.

PMID:
17804676
41.

Simultaneous quantification of seven prostanoids using liquid chromatography/tandem mass spectrometry: the effects of arachidonic acid on prostanoid production in mouse bone marrow-derived mast cells.

Hishinuma T, Suzuki K, Saito M, Yamaguchi H, Suzuki N, Tomioka Y, Kaneko I, Ono M, Goto J.

Prostaglandins Leukot Essent Fatty Acids. 2007 Jun;76(6):321-9. Epub 2007 Jun 21.

PMID:
17590322
42.

[Long-lasting sensitization to footshock after chronic variable stress on the acoustic startle reflex].

Kanai S, Asakura M, Nakano M, Tanaka D, Hishinuma T, Misonoo A, Osada K.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2007 Feb;27(1):13-8. Japanese.

PMID:
17393775
43.

LC/ESI-tandem mass spectrometric determination of bile acid 3-sulfates in human urine 3beta-Sulfooxy-12alpha-hydroxy-5beta-cholanoic acid is an abundant nonamidated sulfate.

Goto T, Myint KT, Sato K, Wada O, Kakiyama G, Iida T, Hishinuma T, Mano N, Goto J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 1;846(1-2):69-77. Epub 2006 Sep 1.

PMID:
16949895
44.

Genetic variation in ABCB1 influences paclitaxel pharmacokinetics in Japanese patients with ovarian cancer.

Yamaguchi H, Hishinuma T, Endo N, Tsukamoto H, Kishikawa Y, Sato M, Murai Y, Hiratsuka M, Ito K, Okamura C, Yaegashi N, Suzuki N, Tomioka Y, Goto J.

Int J Gynecol Cancer. 2006 May-Jun;16(3):979-85.

PMID:
16803472
45.

Preparation of neocarzinostatin apoprotein mutants and the randomized library on the chromophore-binding cavity.

Tomioka Y, Kisara S, Yoshizawa S, Ozawa M, Suzuki N, Yamaguchi H, Hishinuma T, Mizugaki M, Goto J.

Biol Pharm Bull. 2006 May;29(5):1010-4.

46.

Simultaneous determination of pancuronium, vecuronium and their related compounds using LC-ESI-MS.

Usui K, Hishinuma T, Yamaguchi H, Saga T, Wagatsuma T, Hoshi K, Tachiiri N, Miura K, Goto J.

Leg Med (Tokyo). 2006 May;8(3):166-71. Epub 2006 Apr 18.

PMID:
16621652
47.

Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3.

Yamaguchi H, Okada M, Akitaya S, Ohara H, Mikkaichi T, Ishikawa H, Sato M, Matsuura M, Saga T, Unno M, Abe T, Mano N, Hishinuma T, Goto J.

J Lipid Res. 2006 Jun;47(6):1196-202. Epub 2006 Mar 13.

48.

Determination of chlorhexidine (CHD) and nonylphenolethoxylates (NPEOn) using LC-ESI-MS method and application to hemolyzed blood.

Usui K, Hishinuma T, Yamaguchi H, Tachiiri N, Goto J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):105-9. Epub 2005 Dec 27.

PMID:
16380301
49.

A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons.

Asaoka K, Ikeda K, Hishinuma T, Horie-Inoue K, Takeda S, Inoue S.

Biochem Biophys Res Commun. 2005 Dec 30;338(4):1950-6. Epub 2005 Nov 11.

PMID:
16289103
50.

High sensitive analysis of rat serum bile acids by liquid chromatography/electrospray ionization tandem mass spectrometry.

Ando M, Kaneko T, Watanabe R, Kikuchi S, Goto T, Iida T, Hishinuma T, Mano N, Goto J.

J Pharm Biomed Anal. 2006 Mar 18;40(5):1179-86. Epub 2005 Oct 20.

PMID:
16242877

Supplemental Content

Loading ...
Support Center